Cited by 45

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Discovering the 3′ UTR-mediated regulation of alpha-synuclein

Marchese, Domenica, Botta-Orfila, Teresa, Cirillo, Davide, Rodriguez, Juan Antonio, Livi, Carmen Maria, Fernández-Santiago, Rubén, Ezquerra, Mario, Martí, Maria J, Bechara, Elias, Tartaglia, Gian Gaetano, Catalan MSA Registry (CMSAR), Ávila, Asunción, Bayés, Àngels, Botta-Orfila, Teresa, Caballol, Núria, Calopa, Matilde, Campdelacreu, Jaume, Compta, Yaroslau, Ezquerra, Mario, de Fàbregues, Oriol, Fernández-Santiago, Rubén, Girado, Darly, Hernández-Vara, Jorge, Jaumà, Serge, Marchese, Domenica, Martí, Maria J, Pagonabarraga, Javier, Pastor, Pau, Planellas, Lluís, Pont-Sunyer, Claustre, Puente, Víctor, Pujol, Montserrat, Saura, Josep, Tartaglia, Gian Gaetano, Tolosa, Eduard, Valldeoriola, Francesc·2017·Nucleic Acids Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkx1048

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 85

  1. Dauer, 2003, Parkinson's disease: mechanisms and models, Neuron, 39, 889, 10.1016/S0896-6273(03)00568-3 · DOI · Paper page
  2. Spillantini, 1997, Alpha-synuclein in Lewy bodies, Nature, 388, 839, 10.1038/42166 · DOI · Paper page
  3. Zanzoni, 2013, Principles of self-organization in biological pathways: a hypothesis on the autogenous association of alpha-synuclein, Nucleic Acids Res., 41, 9987, 10.1093/nar/gkt794 · DOI
  4. Rhinn, 2012, Alternative α-synuclein transcript usage as a convergent mechanism in Parkinson's disease pathology, Nat. Commun., 3, 1084, 10.1038/ncomms2032 · DOI · Paper page
  5. Locascio, 2015, Association between α-synuclein blood transcripts and early, neuroimaging-supported Parkinson's disease, Brain, 138, 2659, 10.1093/brain/awv202 · DOI
  6. van Raaij, 2008, Concentration dependence of alpha-synuclein fibril length assessed by quantitative atomic force microscopy and statistical-mechanical theory, Biophys. J., 95, 4871, 10.1529/biophysj.107.127464 · DOI
  7. Siprashvili, 2012, Identification of proteins binding coding and non-coding human RNAs using protein microarrays, BMC Genomics, 13, 633, 10.1186/1471-2164-13-633 · DOI
  8. Sotiriou, 2009, A single nucleotide polymorphism in the 3′UTR of the SNCA gene encoding alpha-synuclein is a new potential susceptibility locus for Parkinson disease, Neurosci. Lett., 461, 196, 10.1016/j.neulet.2009.06.034 · DOI · Paper page
  9. Hämmerle, 2013, Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1), Hepatol. Baltim. MD, 58, 1703, 10.1002/hep.26537 · DOI
  10. Kretz, 2013, Control of somatic tissue differentiation by the long non-coding RNA TINCR, Nature, 493, 231, 10.1038/nature11661 · DOI
  11. Cirillo, 2016, Quantitative predictions of protein interactions with long noncoding RNAs, Nat. Methods, 14, 5, 10.1038/nmeth.4100 · DOI
  12. Agostini, 2013, catRAPID omics: a web server for large-scale prediction of protein-RNA interactions, Bioinforma. Oxf. Engl., 29, 2928, 10.1093/bioinformatics/btt495 · DOI · Paper page
  13. Bellucci, 2011, Predicting protein associations with long noncoding RNAs, Nat. Methods, 8, 444, 10.1038/nmeth.1611 · DOI
  14. Santiago, 2015, Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease, Proc. Natl. Acad. Sci. U.S.A., 112, 2257, 10.1073/pnas.1423573112 · DOI
  15. Cok, 2003, The proximal region of the 3′-untranslated region of cyclooxygenase-2 is recognized by a multimeric protein complex containing HuR, TIA-1, TIAR, and the heterogeneous nuclear ribonucleoprotein U, J. Biol. Chem., 278, 36157, 10.1074/jbc.M302547200 · DOI
  16. Izquierdo, 2006, Control of the ATP synthase beta subunit expression by RNA-binding proteins TIA-1, TIAR, and HuR, Biochem. Biophys. Res. Commun., 348, 703, 10.1016/j.bbrc.2006.07.114 · DOI
  17. Kim, 2011, Different modes of interaction by TIAR and HuR with target RNA and DNA, Nucleic Acids Res., 39, 1117, 10.1093/nar/gkq837 · DOI
  18. Subramaniam, 2011, The 3′-untranslated region length and AU-rich RNA location modulate RNA-protein interaction and translational control of β2-adrenergic receptor mRNA, Mol. Cell. Biochem., 352, 125, 10.1007/s11010-011-0747-z · DOI
  19. Suswam, 2005, IL-1beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3′ untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR, Int. J. Cancer, 113, 911, 10.1002/ijc.20675 · DOI
  20. Wigington, 2015, Post-transcriptional regulation of programmed cell death 4 (PDCD4) mRNA by the RNA-binding proteins human antigen R (HuR) and T-cell intracellular antigen 1 (TIA1), J. Biol. Chem., 290, 3468, 10.1074/jbc.M114.631937 · DOI
  21. Dassi, 2012, AURA: Atlas of UTR Regulatory Activity, Bioinforma. Oxf. Engl., 28, 142, 10.1093/bioinformatics/btr608 · DOI
  22. Dassi, 2014, AURA 2: Empowering discovery of post-transcriptional networks, Transl. Austin Tex, 2, e27738
  23. Korecka, 2013, Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling, PloS One, 8, e63862, 10.1371/journal.pone.0063862 · DOI
  24. Miura, 2013, Widespread and extensive lengthening of 3′ UTRs in the mammalian brain, Genome Res., 23, 812, 10.1101/gr.146886.112 · DOI
  25. Kishore, 2011, A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins, Nat. Methods, 8, 559, 10.1038/nmeth.1608 · DOI
  26. Mukherjee, 2011, Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability, Mol. Cell, 43, 327, 10.1016/j.molcel.2011.06.007 · DOI · Paper page
  27. Lebedeva, 2011, Transcriptome-wide Analysis of Regulatory Interactions of the RNA-Binding Protein HuR, Mol. Cell, 43, 340, 10.1016/j.molcel.2011.06.008 · DOI · Paper page
  28. Wang, 2010, iCLIP predicts the dual splicing effects of TIA-RNA interactions, PLoS Biol., 8, e1000530, 10.1371/journal.pbio.1000530 · DOI
  29. Chartier-Harlin, 2004, Alpha-synuclein locus duplication as a cause of familial Parkinson's disease, Lancet Lond. Engl., 364, 1167, 10.1016/S0140-6736(04)17103-1 · DOI · Paper page
  30. Chiba-Falek, 2001, Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system, Hum. Mol. Genet., 10, 3101, 10.1093/hmg/10.26.3101 · DOI
  31. Brennan, 2001, HuR and mRNA stability, Cell. Mol. Life Sci. CMLS, 58, 266, 10.1007/PL00000854 · DOI · Paper page
  32. Peng, 1998, RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein, EMBO J., 17, 3461, 10.1093/emboj/17.12.3461 · DOI
  33. Kedersha, 1999, RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules, J. Cell Biol., 147, 1431, 10.1083/jcb.147.7.1431 · DOI
  34. Mazan-Mamczarz, 2006, Translational repression by RNA-binding protein TIAR, Mol. Cell. Biol., 26, 2716, 10.1128/MCB.26.7.2716-2727.2006 · DOI
  35. Podszywalow-Bartnicka, 2014, Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation, Cell Cycle Georget. Tex, 13, 3727, 10.4161/15384101.2014.965013 · DOI
  36. Schneider, 2012, NIH Image to ImageJ: 25 years of image analysis, Nat. Methods, 9, 671, 10.1038/nmeth.2089 · DOI · Paper page
  37. Xu, 2010, Loss of repression of HuR translation by miR-16 may be responsible for the elevation of HuR in human breast carcinoma, J. Cell. Biochem., 111, 727, 10.1002/jcb.22762 · DOI
  38. Choudhury, 2013, Tissue-specific control of brain-enriched miR-7 biogenesis, Genes Dev., 27, 24, 10.1101/gad.199190.112 · DOI · Paper page
  39. Junn, 2009, Repression of alpha-synuclein expression and toxicity by microRNA-7, Proc. Natl. Acad. Sci. U.S.A., 106, 13052, 10.1073/pnas.0906277106 · DOI · Paper page
  40. Doxakis, 2010, Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153, J. Biol. Chem., 285, 12726, 10.1074/jbc.M109.086827 · DOI · Paper page
  41. Ru, 2014, The multiMiR R package and database: integration of microRNA–target interactions along with their disease and drug associations, Nucleic Acids Res., 42, e133, 10.1093/nar/gku631 · DOI
  42. Grolmusz, 2016, Fluorescence activated cell sorting followed by small RNA sequencing reveals stable microRNA expression during cell cycle progression, BMC Genomics, 17, 412, 10.1186/s12864-016-2747-6 · DOI
  43. Cykowski, 2015, Expanding the spectrum of neuronal pathology in multiple system atrophy, Brain J. Neurol., 138, 2293, 10.1093/brain/awv114 · DOI · Paper page
  44. Halliday, 2011, Neuropathology underlying clinical variability in patients with synucleinopathies, Acta Neuropathol. (Berl.), 122, 187, 10.1007/s00401-011-0852-9 · DOI
  45. Churchyard, 1993, Dopa resistance in multiple-system atrophy: loss of postsynaptic D2 receptors, Ann. Neurol., 34, 219, 10.1002/ana.410340219 · DOI
  46. Wenning, 1994, Clinical features and natural history of multiple system atrophy. An analysis of 100 cases, Brain J. Neurol., 117, 835, 10.1093/brain/117.4.835 · DOI
  47. Al-Chalabi, 2009, Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy, PloS One, 4, e7114, 10.1371/journal.pone.0007114 · DOI
  48. Houlden, 2016, Updates on potential therapeutic targets in MSA, ACNR, 15, 8
  49. Scholz, 2009, SNCA variants are associated with increased risk for multiple system atrophy, Ann. Neurol., 65, 610, 10.1002/ana.21685 · DOI
  50. Neystat, 1999, Alpha-synuclein expression in substantia nigra and cortex in Parkinson's disease, Mov. Disord. Off. J. Mov. Disord. Soc., 14, 417, 10.1002/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X · DOI
  51. Kingsbury, 2004, Alteration in alpha-synuclein mRNA expression in Parkinson's disease, Mov. Disord. Off. J. Mov. Disord. Soc., 19, 162, 10.1002/mds.10683 · DOI
  52. Asi, 2014, Alpha-synuclein mRNA expression in oligodendrocytes in MSA, Glia, 62, 964, 10.1002/glia.22653 · DOI
  53. Mills, 2016, Strand-specific RNA-sequencing analysis of multiple system atrophy brain transcriptome, Neuroscience, 322, 234, 10.1016/j.neuroscience.2016.02.042 · DOI
  54. Kircher, 2014, A general framework for estimating the relative pathogenicity of human genetic variants, Nat. Genet., 46, 310, 10.1038/ng.2892 · DOI · Paper page
  55. Pickrell, 2016, Detection and interpretation of shared genetic influences on 42 human traits, Nat. Genet., 48, 709, 10.1038/ng.3570 · DOI · Paper page
  56. Lill, 2012, Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: the PDGene Database, PLOS Genet., 8, e1002548, 10.1371/journal.pgen.1002548 · DOI
  57. Cirillo, 2014, Constitutive patterns of gene expression regulated by RNA-binding proteins, Genome Biol., 15, R13, 10.1186/gb-2014-15-1-r13 · DOI
  58. Cirillo, 2014, Discovery of protein–RNA networks, Mol. Biosyst., 10, 1632, 10.1039/C4MB00099D · DOI
  59. GTEx Consortium, 2013, The Genotype-Tissue Expression (GTEx) project, Nat. Genet., 45, 580, 10.1038/ng.2653 · DOI · Paper page
  60. Purcell, 2007, PLINK: a tool set for whole-genome association and population-based linkage analyses, Am. J. Hum. Genet., 81, 559, 10.1086/519795 · DOI · Paper page
  61. Lautenschläger, 2017, α-Synuclein - Regulator of Exocytosis, Endocytosis, or Both, Trends Cell Biol., 27, 468, 10.1016/j.tcb.2017.02.002 · DOI
  62. Wong, 2017, α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies, Nat. Med., 23, 1, 10.1038/nm.4269 · DOI · Paper page
  63. Rocha, 2017, Alpha-synuclein: pathology, mitochondrial dysfunction and neuroinflammation in Parkinson's disease, Neurobiol. Dis.
  64. Cok, 2004, Identification of RNA-binding proteins in RAW 264.7 cells that recognize a lipopolysaccharide-responsive element in the 3-untranslated region of the murine cyclooxygenase-2 mRNA, J. Biol. Chem., 279, 8196, 10.1074/jbc.M308475200 · DOI
  65. Dai, 2012, RNA-binding protein HuR autoregulates its expression by promoting alternative polyadenylation site usage, Nucleic Acids Res., 40, 787, 10.1093/nar/gkr783 · DOI
  66. Lu, 2014, ELAVL1 modulates transcriptome-wide miRNA binding in murine macrophages, Cell Rep., 9, 2330, 10.1016/j.celrep.2014.11.030 · DOI
  67. Srikantan, 2012, Functional interplay between RNA-binding protein HuR and microRNAs, Curr. Protein Pept. Sci., 13, 372, 10.2174/138920312801619394 · DOI
  68. Wolozin, 2012, Regulated protein aggregation: stress granules and neurodegeneration, Mol. Neurodegener., 7, 56, 10.1186/1750-1326-7-56 · DOI
  69. Ash, 2014, Pathological stress granules in Alzheimer's disease, Brain Res., 1584, 52, 10.1016/j.brainres.2014.05.052 · DOI · Paper page
  70. Goggin, 2008, Prion protein aggresomes are poly(A)+ ribonucleoprotein complexes that induce a PKR-mediated deficient cell stress response, Biochim. Biophys. Acta, 1783, 479, 10.1016/j.bbamcr.2007.10.008 · DOI
  71. Vanderweyde, 2016, Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity, Cell Rep., 15, 1455, 10.1016/j.celrep.2016.04.045 · DOI
  72. Waelter, 2001, Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation, Mol. Biol. Cell, 12, 1393, 10.1091/mbc.12.5.1393 · DOI
  73. Bolognesi, 2016, A Concentration-Dependent Liquid Phase Separation Can Cause Toxicity upon Increased Protein Expression, Cell Rep., 16, 222, 10.1016/j.celrep.2016.05.076 · DOI
  74. Skliris, 2015, Neuroprotection requires the functions of the RNA-binding protein HuR, Cell Death Differ., 22, 703, 10.1038/cdd.2014.158 · DOI
  75. Gueydan, 1999, Identification of TIAR as a protein binding to the translational regulatory AU-rich element of tumor necrosis factor alpha mRNA, J. Biol. Chem., 274, 2322, 10.1074/jbc.274.4.2322 · DOI
  76. Dixon, 2003, Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1, J. Exp. Med., 198, 475, 10.1084/jem.20030616 · DOI
  77. Kawai, 2006, Translational control of cytochrome c by RNA-binding proteins TIA-1 and HuR, Mol. Cell. Biol., 26, 3295, 10.1128/MCB.26.8.3295-3307.2006 · DOI
  78. Liu, 2003, Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention, J. Pharmacol. Exp. Ther., 304, 1, 10.1124/jpet.102.035048 · DOI · Paper page
  79. Ishizawa, 2004, Microglial activation parallels system degeneration in multiple system atrophy, J. Neuropathol. Exp. Neurol., 63, 43, 10.1093/jnen/63.1.43 · DOI · Paper page
  80. Langerveld, 2007, Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients, Mov. Disord. Off. J. Mov. Disord. Soc., 22, 766, 10.1002/mds.21259 · DOI
  81. Infante, 2005, Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-alpha gene polymorphisms and the risk for multiple system atrophy, J. Neurol. Sci., 228, 11, 10.1016/j.jns.2004.09.023 · DOI
  82. Nishimura, 2002, Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy, Mov. Disord. Off. J. Mov. Disord. Soc., 17, 808, 10.1002/mds.10124 · DOI
  83. Jecmenica-Lukic, 2012, Premotor signs and symptoms of multiple system atrophy, Lancet Neurol., 11, 361, 10.1016/S1474-4422(12)70022-4 · DOI
  84. Petrovic, 2012, Multiple system atrophy-parkinsonism with slow progression and prolonged survival: a diagnostic catch, Mov. Disord. Off. J. Mov. Disord. Soc., 27, 1186, 10.1002/mds.25115 · DOI
  85. Compta, 2017, Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy, Parkinsonism and Related Disorders

Cited by

Sorted by citations

Metadata

Authors
Marchese, D., Botta-Orfila, T., Cirillo, D., Rodriguez, J. A., Livi, C. M., Fernández-Santiago, R., Ezquerra, M., Martí, M. J., Bechara, E., Tartaglia, G. G., Catalan MSA Registry (CMSAR), Ávila, A., Bayés, À., Botta-Orfila, T., Caballol, N., Calopa, M., Campdelacreu, J., Compta, Y., Ezquerra, M., de Fàbregues, O., Fernández-Santiago, R., Girado, D., Hernández-Vara, J., Jaumà, S., Marchese, D., Martí, M. J., Pagonabarraga, J., Pastor, P., Planellas, L., Pont-Sunyer, C., Puente, V., Pujol, M., Saura, J., Tartaglia, G. G., Tolosa, E., & Valldeoriola, F.
Affiliations
  • Centre for Genomic Regulation (CRG), The Barcelona Institute for Science and Technology, Dr. Aiguader 88, 08003 Barcelona, Spain
  • Universitat Pompeu Fabra (UPF), Barcelona, Spain
Venue
Nucleic Acids Research
Published
2017-11-15
Volume
45
Issue
22
Pages
12888-12903
ISSN
  • 0305-1048
  • 1362-4962
Cited by
45
References
4
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review